Index of /wp-content/uploads/2020/05/
| Name | Last Modified | Size |
|---|---|---|
 Parent Directory | ||
 Executive-summary-Zolgensma-Beneluxa-IrelandFinal-Version.pdf | 2023-03-09 11:31 | 543k |
| NCPE-Durvalumab-Plain-English-Summary-07_05.pdf | 2023-03-09 11:31 | 201k |
| NCPE-Durvalumab-technical-summary-07_05-2.pdf | 2023-03-09 11:31 | 330k |
| Plain-English-Summary-darolutamide-nmCRPC.-20022.pdf | 2023-03-09 11:31 | 240k |
| Plain-English-Summary-letermovir.pdf | 2023-03-09 11:31 | 199k |
| Plain-English-Summary_Pembrolizumab-May-2020.pdf | 2023-03-09 11:31 | 207k |
| Technical-Summary-Darolutamide-Nubeqa-20022.pdf | 2023-03-09 11:31 | 324k |
| Technical-Summary_Pembrolizumab-May-2020.pdf | 2023-03-09 11:31 | 306k |
| Website-Summary-Letermovir.pdf | 2023-03-09 11:31 | 308k |